0000914190-17-000026.txt : 20170203 0000914190-17-000026.hdr.sgml : 20170203 20170203185403 ACCESSION NUMBER: 0000914190-17-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170201 FILED AS OF DATE: 20170203 DATE AS OF CHANGE: 20170203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gavin Robert M. CENTRAL INDEX KEY: 0001608023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 17573622 MAIL ADDRESS: STREET 1: C/O PROTEINSIMPLE STREET 2: 3040 OAKMEAD VILLAGE DRIVE CITY: SANTA CLARA STATE: CA ZIP: 95051 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-02-01 0000842023 BIO-TECHNE Corp TECH 0001608023 Gavin Robert M. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 Senior V.P. Protein Platforms Common Stock 2017-02-01 4 M 0 1667 0 A 1667 D Stock Option (Right to Buy) 93.32 2021-07-31 Common Stock 10000 10000 D Stock Option (Right to Buy) 93.32 2017-02-01 4 D 0 33333 0 D 2021-07-31 Common Stock 33333 16667 D Stock Option (Right to Buy) 90.25 2021-11-30 Common Stock 5000 5000 D Restricted Stock Units 2017-02-01 4 M 0 1667 0 D Common Stock 1667 0 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 12500 12500 D Stock Option (Right to Buy) 108.49 2022-08-07 Common Stock 9375 9375 D Restricted Stock Units Common Stock 1500 1500 D Stock Option (Right to Buy) 106.59 2016-08-18 4 A 0 17371 0 A 2023-08-18 Common Stock 17371 17371 D Stock Option (Right to Buy) 106.59 2016-08-18 4 A 0 13028 0 A 2023-08-18 Common Stock 13028 13028 D Restricted Stock Units 2016-08-18 4 A 0 2111 0 A Common Stock 2111 2111 D 2,500 shares vest on each of 7/31/15, 7/31/16, 7/31/17 and 7/31/18. On 2/1/17, the Board of Directors authorized discretionary vesting for 16,667 performance options. The remainder of the performance options were forfeited. 1,500 shares vest on each of 12/1/15, 12/1/16, 12/1/17 and 12/1/18. On 2/1/17, the Board of Directors authorized discretionary vesting for 1,667 performance RSUs. The remainder of the performance RSUs were foreited. 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19. Each restricted stock unit represents a contingent right to receive one shares of Bio-Techne common stock. Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20. Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). /s/ Elizabeth M. Dunshee as Attorney-in-Fact for Robert M. Gavin pursuant to Power of Attorney previously filed. 2017-02-03